Aarti Pharmalabs Limited (AARTIPHARM) — Cash Flow Reinvestment Rate
Aarti Pharmalabs Limited (AARTIPHARM) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs375.40 Million. See free cash flow generation of Aarti Pharmalabs Limited to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aarti Pharmalabs Limited Cash Flow Reinvestment Rate (2023–2025)
Historical reinvestment intensity for Aarti Pharmalabs Limited across 3 annual periods. For the full cash flow conversion analysis, see AARTIPHARM operating cash flow.
Annual Cash Flow Reinvestment Rate for Aarti Pharmalabs Limited (2023–2025)
Year-by-year capital reinvestment analysis for Aarti Pharmalabs Limited. See AARTIPHARM free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.21x | Rs4.02 Billion | Rs3.32 Billion | Rs4.02 Billion | ▲ +32.0% |
| 2024 | 0.92x | Rs1.99 Billion | Rs2.16 Billion | Rs1.99 Billion | ▼ -12.9% |
| 2023 | 1.06x | Rs2.77 Billion | Rs2.63 Billion | Rs1.20 Billion | — |